186 related articles for article (PubMed ID: 21339042)
21. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
Cui W; Yu CH; Hu KQ
Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway.
Luna M; Wong S; Ferrario A; Gomer CJ
Photochem Photobiol; 2008; 84(2):509-14. PubMed ID: 18282182
[TBL] [Abstract][Full Text] [Related]
23. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
Kardosh A; Soriano N; Pyrko P; Liu YT; Jabbour M; Hofman FM; Schönthal AH
J Biomed Sci; 2007 Sep; 14(5):647-62. PubMed ID: 17440835
[TBL] [Abstract][Full Text] [Related]
24. Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress.
Cho HY; Thomas S; Golden EB; Gaffney KJ; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
Cancer Lett; 2009 Sep; 282(1):87-97. PubMed ID: 19345476
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
26. Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer.
Backhus LM; Petasis NA; Uddin J; Schönthal AH; Bart RD; Lin Y; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1406-12. PubMed ID: 16256796
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential.
Yang P; Zhang Y; Ping L; Gao XM
Int Immunopharmacol; 2007 Nov; 7(11):1414-21. PubMed ID: 17761345
[TBL] [Abstract][Full Text] [Related]
29. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
[TBL] [Abstract][Full Text] [Related]
30. Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
Pyrko P; Kardosh A; Liu YT; Soriano N; Xiong W; Chow RH; Uddin J; Petasis NA; Mircheff AK; Farley RA; Louie SG; Chen TC; Schönthal AH
Mol Cancer Ther; 2007 Apr; 6(4):1262-75. PubMed ID: 17431104
[TBL] [Abstract][Full Text] [Related]
31. Celecoxib transiently inhibits cellular protein synthesis.
Pyrko P; Kardosh A; Schönthal AH
Biochem Pharmacol; 2008 Jan; 75(2):395-404. PubMed ID: 17920040
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
Yu L; Chen M; Li Z; Wen J; Fu J; Guo D; Jiang Y; Wu S; Cho CH; Liu S
Mol Pharmacol; 2011 Mar; 79(3):608-17. PubMed ID: 21177414
[TBL] [Abstract][Full Text] [Related]
33. Targeting the tumor microenvironment using photodynamic therapy combined with inhibitors of cyclooxygenase-2 or vascular endothelial growth factor.
Ferrario A; Gomer CJ
Methods Mol Biol; 2010; 635():121-32. PubMed ID: 20552344
[TBL] [Abstract][Full Text] [Related]
34. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
35. Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP.
He Q; Luo X; Jin W; Huang Y; Reddy MV; Reddy EP; Sheikh MS
Oncogene; 2008 Apr; 27(18):2656-60. PubMed ID: 17968315
[TBL] [Abstract][Full Text] [Related]
36. Celecoxib induces cell apoptosis coupled with up-regulation of the expression of VEGF by a mechanism involving ER stress in human colorectal cancer cells.
Du H; Li W; Wang Y; Chen S; Zhang Y
Oncol Rep; 2011 Aug; 26(2):495-502. PubMed ID: 21567098
[TBL] [Abstract][Full Text] [Related]
37. COX-2 expression in chondrosarcoma: a role for celecoxib treatment?
Schrage YM; Machado I; Meijer D; Briaire-de Bruijn I; van den Akker BE; Taminiau AH; Kalinski T; Llombart-Bosch A; Bovée JV
Eur J Cancer; 2010 Feb; 46(3):616-24. PubMed ID: 20004565
[TBL] [Abstract][Full Text] [Related]
38. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
39. Targeting apoptosis pathways by Celecoxib in cancer.
Jendrossek V
Cancer Lett; 2013 May; 332(2):313-24. PubMed ID: 21345578
[TBL] [Abstract][Full Text] [Related]
40. Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Ferrario A; Luna M; Rucker N; Wong S; Gomer CJ
Lasers Surg Med; 2011 Sep; 43(7):644-50. PubMed ID: 22057492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]